5m Read
December 03, 2024
Learn more about the Baby Cure trial at Queen Nandi Regional Hospital and how Cepheid's test has a global impact on HIV screening for the infant population.
5m Read
December 03, 2024
Cepheid is tracking the mpox outbreak in Africa to ensure quality diagnostic tests are available to help address the recent international health emergency.
5m Read
December 03, 2024
Hepatitis C Virus (HCV) testing in the U.S. is inadequate to achieve the goal of HCV elimination. Learn about the shortfalls of the current diagnostic algorithm and how key learnings and real-world implementation in other nations can help us achieve our goals.
5m Read
November 18, 2024
COMMUNITY AND GLOBAL HEALTH
2m Read
September 19, 2024
COMMUNITY AND GLOBAL HEALTH
Learn how POC Hepatitis C Virus testing system dramatically reduced the time from test to treatment in one London prison.
1m Read
September 19, 2024
COMMUNITY AND GLOBAL HEALTH
Checkpoint clinics in spain improve access to screening and treatment of sexually transmitted diseases using point-of-care testing.
5m Read
September 18, 2024
COMMUNITY AND GLOBAL HEALTH
Molecular tests like Cepheid’s Xpert® technology can help close the diagnostic gap in tuberculosis treatment – a key step to eliminating the disease.
2m Read
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
A Danish mobile service features a mobile HCV RNA POC testing facility that brings HCV testing, using the GeneXpert® system, to a population that is often not reached through traditional healthcare pathways.
2m Read
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Research in Finland showcases the benefits of universal intrapartum PCR screening for GBS. Learn more about the implications and advancements in maternal health today.
6m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
The WHO has set a goal to eliminate Hep C by 2030. Learn how Cepheid plans to help achieve this goal.
3m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Dr. Sifumba speaks about improving access to molecular diagnostics across the globe.
2m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Friends for International TB Relief addresses the importance of access to fast molecular diagnostics in the fight to End TB by the year 2030.
2m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Cepheid opens new manufacturing facility in Banglore, India to support global efforts to win against tuberculosis.
5m Read
November 18, 2024
COMMUNITY AND GLOBAL HEALTH
2m Read
September 19, 2024
COMMUNITY AND GLOBAL HEALTH
Learn how POC Hepatitis C Virus testing system dramatically reduced the time from test to treatment in one London prison.
1m Read
September 19, 2024
COMMUNITY AND GLOBAL HEALTH
Checkpoint clinics in spain improve access to screening and treatment of sexually transmitted diseases using point-of-care testing.
5m Read
September 18, 2024
COMMUNITY AND GLOBAL HEALTH
Molecular tests like Cepheid’s Xpert® technology can help close the diagnostic gap in tuberculosis treatment – a key step to eliminating the disease.
2m Read
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
A Danish mobile service features a mobile HCV RNA POC testing facility that brings HCV testing, using the GeneXpert® system, to a population that is often not reached through traditional healthcare pathways.
2m Read
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Research in Finland showcases the benefits of universal intrapartum PCR screening for GBS. Learn more about the implications and advancements in maternal health today.
6m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
The WHO has set a goal to eliminate Hep C by 2030. Learn how Cepheid plans to help achieve this goal.
3m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Dr. Sifumba speaks about improving access to molecular diagnostics across the globe.
2m Watch
September 11, 2024
COMMUNITY AND GLOBAL HEALTH
Friends for International TB Relief addresses the importance of access to fast molecular diagnostics in the fight to End TB by the year 2030.